Skip to content

Reassessment of Premedication in Surgery

Assessment of Two Modes of Premedication in Surgery - PREMED Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01549691
Acronym
PREMED
Enrollment
455
Registered
2012-03-09
Start date
2012-03-31
Completion date
2013-04-30
Last updated
2013-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Keywords

Premedication, Benzodiazepine, Anti-anxiety agents, Anxiety, Surgery, Adult, Human

Brief summary

The purpose of this study is to test the level of anxiety in patients, the day before surgery (late afternoon) and immediately prior to surgery in 3 parallel groups of patients. * one receiving placebo before going to sleep (before sleep), the day prior surgery and placebo when awakening (awakening), the day of surgery * one receiving zopiclone (7.5 mg) before sleep and placebo at awakening * one receiving placebo before sleep and alprazolam (0.5 mg)at awakening double blind, randomized controlled study

Detailed description

Eligibility: * 18 to 65 years old * elective surgery * in-hospital preoperative night Outcome measures: * anxiety scales * demographic data

Interventions

DRUGZopiclone

7.5 mg before sleep, the evening before surgery

DRUGAlprazolam

0.5 mg at awakening, the day of surgery

DRUGplacebo

given night before surgery and at awakening, the day of surgery

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age 18-65 years old * elective surgery * in-hospital night before surgery

Exclusion criteria

* myasthenia gravis * chronic intake of psychotropic drugs * opiates intake * severe obstructive sleep apnea * intracranial hypertension * morbid obesity * myasthenia gravis * acute severe medical disorder * non health insurance coverage * protected patients by law * pregnancy * non French speaking

Design outcomes

Primary

MeasureTime frameDescription
anxiety scalesduration of the study : 12 hours (one evaluation on late afternoon the day before surgery and the second evaluation on arrival to operating room)\* The day before surgery (late afternoon) : patient's self rating of anxiety and desire of information regarding upcoming surgery (Amsterdam patient anxiety and information scale, APAIS) \* On arrival to the operating room : Recording of the level of declared anxiety (numeric scale similar to that corresponding of the anxiety component of the APAIS scale)

Secondary

MeasureTime frameDescription
markers of stresson arrival to operating room (one single recording)recording of actual (using the operating room monitor): * heart rate (at rest, supine) * systolic blood pressure (at rest, supine)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026